Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,762.40
(
-0.14%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.48
(
-1.97%
)
Bitcoin
70,588.89
(
-0.92%
)
News Focus
News Focus

Replies to post #136190 on Biotech Values

Replies to #136190 on Biotech Values
icon url

buckiii2

02/01/12 6:00 AM

#136201 RE: DewDiligence #136190

Hope results are good for ILNS's sake.
icon url

genisi

02/01/12 8:01 AM

#136205 RE: DewDiligence #136190

The phase-3 Solanezumab trials being conducted by LLY have futility analyses and passed them recently. (Source: LLY’s 4Q11 CC)